Molecular Partners AG
MOLN3.650USD
+0.120+3.40%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
134.55MCap. mercado
PérdidaP/E TTM
Más Datos de Molecular Partners AG Compañía
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Información de la empresa
Símbolo de cotizaciónMOLN
Nombre de la empresaMolecular Partners AG
Fecha de salida a bolsaOct 22, 2014
Director ejecutivoDr. Patrick Amstutz, Ph.D.
Número de empleados159
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 22
DirecciónWagistrasse 14
CiudadSCHLIEREN
Bolsa de valoresSIX Swiss Exchange
PaísSwitzerland
Código postal8952
Teléfono41447557700
Sitio Webhttps://www.molecularpartners.com/
Símbolo de cotizaciónMOLN
Fecha de salida a bolsaOct 22, 2014
Director ejecutivoDr. Patrick Amstutz, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Renate Gloggner
Ms. Renate Gloggner
Executive Vice President - People and Community, Member of the Management Board
Executive Vice President - People and Community, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Alexander Zuercher
Mr. Alexander Zuercher
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Desglose de ingresos
Divisa: CHFActualizado: dom., 6 de jul
Divisa: CHFActualizado: dom., 6 de jul
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónCHF
Nombre
Ganancia
Proporción
Switzerland
4.97M
0.00%
United States
0.00
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Suvretta Capital Management, LLC
6.03%
BVF Partners L.P.
3.67%
UBS Financial Services, Inc.
0.02%
Other
90.28%
Accionistas
Accionistas
Proporción
Suvretta Capital Management, LLC
6.03%
BVF Partners L.P.
3.67%
UBS Financial Services, Inc.
0.02%
Other
90.28%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
9.70%
Investment Advisor
0.02%
Other
90.28%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
16
3.58M
9.72%
-44.38K
2025Q1
16
3.58M
9.72%
-44.38K
2024Q4
16
3.58M
10.80%
+1.75M
2024Q3
19
850.31K
2.56%
-138.97K
2024Q2
20
861.27K
2.60%
-213.87K
2024Q1
22
946.77K
2.88%
-611.83K
2023Q4
26
957.56K
2.63%
-624.65K
2023Q3
28
961.52K
2.93%
-686.56K
2023Q2
36
934.21K
2.85%
-1.24M
2023Q1
36
935.03K
2.59%
-1.23M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Suvretta Capital Management, LLC
2.22M
6.03%
--
--
Mar 31, 2025
BVF Partners L.P.
1.35M
3.67%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
6.35K
0.02%
-521.00
-7.58%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.07K
0%
--
--
May 31, 2025
Morgan Stanley & Co. LLC
367.00
0%
--
--
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
269.00
0%
--
--
Mar 31, 2025
BofA Global Research (US)
157.00
0%
+157.00
--
Mar 31, 2025
Qube Research & Technologies Ltd
--
0%
-16.00
-100.00%
Sep 30, 2024
Old Mission Capital LLC
--
0%
-10.37K
-100.00%
Sep 30, 2024
Susquehanna International Group, LLP
--
0%
-12.62K
-100.00%
Mar 31, 2024
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
